{"transactions":[{"id":3816206,"issuer":{"id":2671,"kind":"organization","name":"Protalix BioTherapeutics, Inc.","symbol":"PLX"},"owners":[{"id":163615,"kind":"person","name":"Shaaltiel Yoseph","position":1,"cik":"0001385118","reported_name":"Shaaltiel Yoseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, R&D"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-09-14T20:30:18.000Z","date":"2018-09-13","kind":"grant","acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the stock options shall vest in 16 equal quarterly installments commencing upon the date of grant. The stock options are subject to accelerated vesting upon a corporate transaction or a change in control as described in the Protalix BioTherapeutics, Inc., 2006 Stock Incentive Plan, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include (i) options to purchase 50,000 shares of common stock at an exercise price equal to $2.65 per share that expire on February 25, 2019; (ii) options to purchase 145,000 shares of common stock at an exercise price equal to $6.90 per share that expire on February 25, 2020; and (iii) options to purchase 275,000 shares of common stock at an exercise price equal to $1.72 per share that expire on March 23, 2025."}],"balance_after":700000,"derivative":{"exercise_price":0.56,"expiration_date":"2028-09-13","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001144204-18-049515","document":"tv502880_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006281/000114420418049515/tv502880_4.xml","form_type":"4"}},{"id":4601888,"issuer":{"id":2671,"kind":"organization","name":"Protalix BioTherapeutics, Inc.","symbol":"PLX"},"owners":[{"id":163615,"kind":"person","name":"Shaaltiel Yoseph","position":1,"cik":"0001385118","reported_name":"Shaaltiel Yoseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, R&D"}}],"security":"Stock Options (Right to Buy)","published_at":"2016-09-16T21:01:28.000Z","date":"2016-09-15","kind":"exercise","acquired":false,"shares":122162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents exercise of all stock underlying the derivative security."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents exercise of all stock underlying the derivative security."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Does not include options to purchase 263,728 shares of common stock at an exercise price equal to $5.00 per share that expire on February 7, 2018; options to purchase 50,000 shares of common stock at an exercise price equal to $2.65 per share that expire on February 25, 2019; options to purchase 145,000 shares of common stock at an exercise price equal to $6.90 per share that expire on February 25, 2020; and options to purchase 275,000 shares of common stock at an exercise price equal to $1.72 per share that expire on March 23, 2025."}],"balance_after":0,"derivative":{"exercise_price":0.001,"underlying":"Common Stock","underlying_shares":122162},"source":{"system":"sec-edgar","filing":"0001144204-16-124284","document":"v448888_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1006281/000114420416124284/v448888_4.xml","form_type":"4"}},{"id":4601887,"issuer":{"id":2671,"kind":"organization","name":"Protalix BioTherapeutics, Inc.","symbol":"PLX"},"owners":[{"id":163615,"kind":"person","name":"Shaaltiel Yoseph","position":1,"cik":"0001385118","reported_name":"Shaaltiel Yoseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, R&D"}}],"security":"Common Stock","published_at":"2016-09-16T21:01:28.000Z","date":"2016-09-15","kind":"exercise","acquired":true,"shares":122162,"price":0.001,"value":122.162,"ownership":{"direct":true},"balance_after":585916,"source":{"system":"sec-edgar","filing":"0001144204-16-124284","document":"v448888_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006281/000114420416124284/v448888_4.xml","form_type":"4"}}]}